1 |
Zarrilli R, Crispino M, Bagattini M, Barretta E, Popolo AD, Triassi M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an Intensive Care Unit shows the emergence of carbapenem resistance. J Clin Microbiol 2004;42:946-53
DOI
ScienceOn
|
2 |
Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. In Vitro Activities of the B-Lactamase Inhibitors Clavulanic Acid, Sulbactam, and Tazobactam Alone or in Combination with B-Lactams against Epidemiologically Characterized Multidrug-Resistant Acinetobacter baumannii Strains. Antimicrob Agents Chemother 2004;48:1586-92
DOI
ScienceOn
|
3 |
Corbella X, Montero A, Pujol M, Dominguez MA, Ayats J, Agrerich MJ, et al. Emergence and Rapid Spread of Carbapenem Resistance during a Large and Sustained Hospital Outbreak of Multiresistant Acinetobacter baumannii. J Clin Microbiol 2000;38:4086-95
|
4 |
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29
DOI
ScienceOn
|
5 |
Paterson DL. Looking for Risk Factors for the Acquisition of Antibiotic Resistance: A 21st-Century Approach. Clin Infect Dis 2002;34:1564-7
DOI
ScienceOn
|
6 |
Lee SO, Kim NJ, Choi SH, Kim TH, Chung JW, Woo JH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004;48:224-8
DOI
ScienceOn
|
7 |
Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378-82
DOI
|
8 |
Bregeon F, Ciais V, Carret V, Gregoire R, Saux P, Gainnier M et al. Is ventilator-associated pneumonia an independent risk factor for death? Anesthesiology 2001;94:554-60
DOI
ScienceOn
|
9 |
Cisneros JM, Rodriguez BJ. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687-93
DOI
ScienceOn
|
10 |
Kollef MH. What is ventilator-associated pneumonia and why is it important? Respir Care 2005;50:714-24
|
11 |
Maniatis AN, Pournaras S, Orkopoulou S, Tassios PT, Legakis NJ. Multiresistant Acinetobacter baumannii isolates in intensive care units in Greece. Clin Microbiol Infect 2003;9:547-53
DOI
ScienceOn
|
12 |
Levin AS. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem. Clin Microbiol Infect 2002;8:144-53
DOI
ScienceOn
|
13 |
Del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle D et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 2005;11:540-6
DOI
ScienceOn
|
14 |
Mulin B, Talon D, Viel JF, Vincent C, Leprat R, Thouverez M et al. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 1995;14:569-76
|
15 |
Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281-8
DOI
ScienceOn
|
16 |
Lee JH, Cheon SC, Jung SH, Phyun LH, Jang MZ, Lee YG, et al. Clinical usefulness of ClinicalPul monary Infection Score of ICU patients with Sputum Culture positive for Multi-drug resistant Acinetobacter baumannii. Tuberc Respir Dis 2003; 55:579-88
|
17 |
Choi JY, Park YS, Cho CH, Park YS, Shin SY, Song YG, et al. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii. Clin Microbiol Infect 2004;10:1098-101
DOI
ScienceOn
|
18 |
Scerpella EG, Wanger AR, Armitige L, Anderlini P, Ericsson CD. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 1995;16:92-7
DOI
ScienceOn
|
19 |
Doi Y, Wachino JI, Yamane K, Shibata N, Yagi T, Shibayama K, et al. Spread of Novel Aminoglycoside Resistance Gene aac(6)-Iad among Acinetobacter Clinical Isolates in Japan. Antimicrob Agents Chemother 2004;48:2075-80
DOI
ScienceOn
|
20 |
Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med 1996;335:1445-53
DOI
ScienceOn
|
21 |
Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995;20:790-6
DOI
ScienceOn
|
22 |
Over U, Gur D, Unal S, Miller GH. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin Microbiol Infect 2001;7:470-8
DOI
ScienceOn
|
23 |
Koeleman JG, Parlevliet GA, Dijkshoorn L, Savelkoul PH, Vandenbroucke-Grauls CM. Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J Hosp Infect 1997;37:113-23
DOI
ScienceOn
|
24 |
Looveren MV, Goossens H. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 2004;10:684-704
DOI
ScienceOn
|
25 |
Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001;29:2303-9
DOI
ScienceOn
|
26 |
Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005;11:115-21
DOI
ScienceOn
|
27 |
Bernabeu-Wittel M, Pichardo C, Garcia-Curiel A, Pachon-Ibanez ME, Ibanez-Martinez J. Jimenez-Mejias ME, et al. Pharmacokinetic /pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia. Clin Microbiol Infect 2005;11:319-25
DOI
ScienceOn
|
28 |
Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-21
DOI
|
29 |
Turner PJ, Greenhalgh JM. The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect 2003;9:563-7
DOI
|
30 |
Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study. Crit Care Med 2003;31;2478-82
DOI
ScienceOn
|